| Not Yet Recruiting | A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorde NCT06689787 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | Acupuncture and Escitalopram for Treating Major Depression Clinical Study NCT05901571 | Shanghai 7th People's Hospital | N/A |
| Recruiting | A Study of Brenipatide in Adult Participants With Major Depressive Disorder NCT07412756 | Eli Lilly and Company | Phase 3 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disord NCT07227454 | Janssen Research & Development, LLC | Phase 3 |
| Withdrawn | Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive NCT05194332 | The University of Texas Health Science Center, Houston | N/A |
| Recruiting | A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants NCT07258485 | Janssen Research & Development, LLC | — |
| Recruiting | The Motor Activity - Subjective Energy (MASE) Project NCT07059234 | University of Bern | N/A |
| Not Yet Recruiting | A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Ma NCT07161492 | Second Xiangya Hospital of Central South University | N/A |
| Recruiting | Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia NCT06982820 | GrayMatters Health Ltd. | N/A |
| Not Yet Recruiting | Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD) NCT06470035 | Neurovalens Ltd. | N/A |
| Recruiting | Dosing rTMS for Depression Post-SCI NCT05553353 | VA Office of Research and Development | N/A |
| Recruiting | Clinical Efficacy, Safety, and Applicability of Home-based Bright Light Therapy in Outpatient Adolescents With NCT06913309 | Peking University Sixth Hospital | N/A |
| Recruiting | Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients NCT06860958 | Tanta University | Phase 3 |
| Recruiting | Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipul NCT05232032 | Mclean Hospital | Phase 2 |
| Recruiting | Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab NCT06136546 | Massachusetts General Hospital | Phase 2 |
| Withdrawn | Pilot Study: Investigating Mood Changes After Slow-wave Enhancement NCT05146427 | University of Pennsylvania | N/A |
| Recruiting | A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder NCT06785012 | Janssen Research & Development, LLC | Phase 2 |
| Enrolling By Invitation | Precision Care for Major Depressive Disorder NCT06580041 | University of California, San Francisco | Phase 4 |
| Recruiting | Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Trea NCT06511908 | National Institute of Mental Health (NIMH) | Phase 2 |
| Recruiting | The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Majo NCT06621394 | University Hospital Tuebingen | N/A |
| Completed | A Study to Test Different Doses of BI 1569912 in People With Depression NCT06558344 | Boehringer Ingelheim | Phase 2 |
| Terminated | A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Maj NCT06635135 | Janssen Research & Development, LLC | Phase 3 |
| Recruiting | Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression NCT06152705 | The Royal Ottawa Mental Health Centre | N/A |
| Not Yet Recruiting | Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial NCT06303076 | Sultan Qaboos University | Phase 4 |
| Not Yet Recruiting | Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder NCT05933538 | Sultan Qaboos University | Phase 4 |
| Recruiting | Comparing the Efficacy of Accelerated vs. Standard fMRI-guided iTBS in Treating Adolescents Depression NCT06528938 | The Royal Ottawa Mental Health Centre | N/A |
| Not Yet Recruiting | bWell-D Pilot Randomized Controlled Trial NCT06546917 | University of British Columbia | N/A |
| Recruiting | Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive NCT06559306 | Janssen Research & Development, LLC | Phase 3 |
| Terminated | A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) W NCT06514742 | Janssen Research & Development, LLC | Phase 3 |
| Terminated | Behavioural Activation Therapy and Esketamine for Resistant Depression NCT06431386 | The Royal's Institute of Mental Health Research | N/A |
| Enrolling By Invitation | Non-invasive Vagus Nerve Stimulation as a Tool to Modulate Stomach-Brain Coupling in Depression NCT06389175 | University of Bonn | N/A |
| Recruiting | Peer-led Intervention for Individuals With Major Depression. NCT06398561 | University of the Balearic Islands | N/A |
| Withdrawn | A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Contr NCT04829669 | Janssen-Cilag Ltd. | — |
| Completed | A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine NCT06280235 | Boehringer Ingelheim | Phase 2 |
| Active Not Recruiting | Psilocybin for Major Depressive Disorder (MDD) NCT06308653 | Usona Institute | Phase 3 |
| Recruiting | The Effects of Exercise on Gut Bacteria, Mood and Cognition in Depression NCT06398496 | University College Cork | N/A |
| Recruiting | Effectiveness of an Ecological Momentary Emotion Regulation Intervention NCT06311136 | Heidelberg University | N/A |
| Terminated | Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression NCT06219681 | Laureate Institute for Brain Research, Inc. | N/A |
| Enrolling By Invitation | Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Th NCT06254144 | Laureate Institute for Brain Research, Inc. | — |
| Recruiting | The Effect of Mindfulness-Based Psychoeducation NCT06417619 | University of Gaziantep | N/A |
| Recruiting | InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI NCT06005194 | University of Washington | N/A |
| Unknown | Transcranial Magnetic Stimulation in Patients With Depression and Non-suicidal Self-injury NCT06110585 | Brain Institute of Rio Grande do Sul | N/A |
| Withdrawn | VA Aripiprazole vs Esketamine for Treatment Resistant Depression NCT05554627 | VA Office of Research and Development | Phase 4 |
| Recruiting | Psychoeducational Intervention for Families With a Member Affected by Major Depression NCT05988333 | University of Campania Luigi Vanvitelli | N/A |
| Recruiting | Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine NCT05915013 | Yale University | Phase 1 |
| Completed | Cannabinoids as a Treatment for Insomnia in Major Depression NCT05041647 | St. Joseph's Healthcare Hamilton | Phase 2 |
| Recruiting | Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation NCT05909267 | Charite University, Berlin, Germany | N/A |
| Active Not Recruiting | Individualized Functional Connectivity Targeting in aiTBS for Depression NCT05680727 | Brigham and Women's Hospital | Phase 2 |
| Completed | The Feasibility, Usability and Satisfaction of an Online Tool for Perinatal Mental Health Problems NCT06035159 | University Hospital, Ghent | N/A |
| Completed | Brain Network Dynamics of Depression During Esketamine Treatment NCT06012916 | University of North Carolina, Chapel Hill | — |
| Active Not Recruiting | A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current NCT05841030 | Janssen Research & Development, LLC | — |
| Unknown | Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms NCT06320028 | University of Arizona | Phase 1 / Phase 2 |
| Completed | Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) NCT05686408 | Tonix Pharmaceuticals, Inc. | Phase 2 |
| Completed | A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to NCT05550532 | Janssen Research & Development, LLC | Phase 3 |
| Recruiting | Prediction of Antidepressant Effects of Electroconvulsive Therapy NCT05630469 | Medical University of Vienna | — |
| Recruiting | Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Ment NCT05491538 | VA Office of Research and Development | N/A |
| Unknown | The Role of Neuromodulation Technique In Depression Disorder NCT05047159 | Shanghai Mental Health Center | N/A |
| Active Not Recruiting | Treating Immuno-metabolic Depression With Anti-inflammatory Drugs NCT05415397 | Amsterdam UMC, location VUmc | Phase 3 |
| Terminated | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) NCT05518149 | Janssen Research & Development, LLC | Phase 3 |
| Unknown | Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56 NCT05488418 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) NCT05708222 | Medibio Limited | — |
| Completed | Trial of Transcranial Photobiomodulation for Depression With PET and EEG Outcomes NCT06934135 | NeuroThera DE | N/A |
| Unknown | The Efficacy of Acupressure Therapy on Patient With Depression NCT05423405 | University Psychiatric Clinics Basel | N/A |
| Unknown | Smartphone App Based CBT Versus Online Group CBT: Randomized, Non-inferiority Clinical Trial NCT05450614 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | An Energetic View on Creativity, Psychopathology and Intelligence: The Brain2Business Study NCT05544877 | Psychiatrische Dienste Thurgau | N/A |
| Completed | A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Mo NCT05455684 | Janssen Research & Development, LLC | Phase 3 |
| Unknown | Microbiotherapy in Characterized Depressive Disorder NCT05280015 | Centre Hospitalier Universitaire de Besancon | Phase 2 |
| Recruiting | Aerobic Versus Leisure Group for Adolescents With Depression NCT05076214 | Lund University Hospital | N/A |
| Terminated | A Randomized Control Trial Treating Depression With Yoga and Coherent Breathing Versus Walking in Veterans NCT03489122 | VA Office of Research and Development | N/A |
| Unknown | Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA NCT05306184 | Radboud University Medical Center | — |
| Withdrawn | Rapid Acting TMS for Suicide Ideation in Depression NCT05100004 | Stanford University | N/A |
| Unknown | The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Diso NCT04984512 | Sunshine Lake Pharma Co., Ltd. | Phase 2 / Phase 3 |
| Terminated | A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a S NCT05109195 | Janssen Research & Development, LLC | — |
| Completed | Synaptic Imaging and Network Activity in Treatment Resistant Depression NCT05870501 | King's College London | N/A |
| Unknown | Treatment of Major Depression by rTMS on Dorsolateral Prefrontal Cortex: Study of Underlying Mechanisms NCT05121129 | Centre Hospitalier Universitaire de Besancon | N/A |
| Terminated | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder NCT04951609 | Janssen Research & Development, LLC | Phase 1 |
| Withdrawn | Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans NCT04893395 | Auburn University | N/A |
| Completed | Probiotics and the Gut Brain Axis- Do Probiotics Interact With the Vagal Nerve? NCT04772664 | Medical University of Graz | N/A |
| Unknown | Sevoflurane for Treatment-Resistant Depression NCT05008939 | Shanghai First Maternity and Infant Hospital | N/A |
| Completed | A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Dep NCT04937829 | Boehringer Ingelheim | Phase 1 |
| Active Not Recruiting | Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS NCT04870255 | Stanford University | N/A |
| Completed | Neuro MRI Biomarkers for Treatment Navigation in Depression NCT05701267 | Eindhoven University of Technology | — |
| Recruiting | Precision Medicine in the Depression Treatment NCT05616559 | Rigshospitalet, Denmark | — |
| Unknown | Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT NCT04661475 | Sultan Qaboos University | Phase 4 |
| Completed | A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Contin NCT04829318 | Janssen-Cilag Ltd. | Phase 4 |
| Unknown | Deep Brain Stimulation for Treatment Resistant Depression NCT05716555 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Completed | Aerobic Group Exercise for Adolescents With Depression NCT04695145 | Lund University Hospital | N/A |
| Completed | Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disord NCT04770454 | Boryung Pharmaceutical Co., Ltd | — |
| Completed | Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression NCT04701866 | Douglas Mental Health University Institute | N/A |
| Unknown | Alpha-Stim AID and Major Depressive Disorder NCT04963907 | Electromedical Products International, Inc. | N/A |
| Completed | Web-based Self-help Intervention for Adolescents With Acute or Remitted Major Depressive Disorder NCT04994470 | Ludwig-Maximilians - University of Munich | N/A |
| Completed | A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of NCT04669665 | Seelos Therapeutics, Inc. | Phase 2 |
| Recruiting | Biomarkers of Depression and Treatment Response NCT04581902 | University of California, San Francisco | N/A |
| Completed | In-person vs. Remote Wellness Support NCT04526067 | The University of Texas Health Science Center at San Antonio | N/A |
| Terminated | Accelerated Bilateral rTMS on Geriatric Depression NCT04486222 | National Taiwan University Hospital | N/A |
| Completed | A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression NCT04521478 | Boehringer Ingelheim | Phase 2 |
| Completed | Cognitive Fitness for Depression in Older Adults NCT04790630 | UConn Health | N/A |
| Completed | A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major D NCT04476030 | Biogen | Phase 3 |
| Unknown | A Study to Evaluate the Benefit of Opti-Me Application to Different Treatments of MDD NCT04148612 | ElMindA Ltd | N/A |
| Completed | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major D NCT04533529 | Janssen Research & Development, LLC | Phase 3 |
| Terminated | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major D NCT04532749 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly NCT04513912 | Janssen Research & Development, LLC | Phase 3 |
| Withdrawn | NESBID: Neuro-Stimulation of the Brain in Depression NCT04159012 | University of Alberta | N/A |
| Completed | A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With NCT04338321 | Janssen-Cilag International NV | Phase 3 |
| Completed | Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major De NCT04301271 | Charite University, Berlin, Germany | Phase 2 |
| Completed | Using Repetitive Transcranial Magnetic Stimulation to Study the Role of Frontostriatal Circuit in Major Depres NCT05212636 | National Cheng-Kung University Hospital | N/A |
| Completed | A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Par NCT04451187 | Janssen Research & Development, LLC | Phase 1 |
| Unknown | Personalized Sertraline Dosing in Patients With Depression NCT05210153 | University of Belgrade | — |
| Unknown | Personalized Escitalopram Dosing in Patients With Depression NCT05210140 | University of Belgrade | — |
| Completed | A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideat NCT04463108 | Janssen-Cilag S.p.A. | — |
| Terminated | A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression NCT04423757 | Boehringer Ingelheim | Phase 2 |
| Completed | A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Diso NCT04442490 | Biogen | Phase 3 |
| Completed | ICBT for Depression - A Factorial Investigation of Kinds of Therapist Support and Self-/Expert-selected Conten NCT04260750 | Linkoeping University | N/A |
| Completed | Antidepressant Decision Aid for Major Depressive Disorder Patients NCT04761757 | University of Malaya | N/A |
| Unknown | Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent NCT04171193 | University of Sao Paulo | Phase 2 |
| Unknown | Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients NCT04179006 | National Cheng-Kung University Hospital | N/A |
| Recruiting | Optimal Electrical Stimulus During Electroconvulsive Therapy NCT04057378 | Region Örebro County | Phase 4 |
| Terminated | Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Sca NCT03872492 | Ad scientiam | N/A |
| Completed | A Study of Psilocybin for Major Depressive Disorder (MDD) NCT03866174 | Usona Institute | Phase 2 |
| Unknown | Antidepressant Trial With P2X7 Antagonist JNJ-54175446 NCT04116606 | CCTU-Core | Phase 2 |
| Terminated | Effectiveness of IPT-G in Major Depression NCT04015206 | Hospital de Clinicas de Porto Alegre | N/A |
| Withdrawn | Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD) NCT03855865 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Unknown | Ketamine for Mood Disorders With Suicidal Ideation NCT04099771 | The Miriam Hospital | EARLY_Phase 1 |
| Completed | Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression NCT03832283 | University of Chicago | N/A |
| Unknown | The Effect of Probiotic Supplementation on the Mental Status, Inflammation, and Intestinal Barrier in Major De NCT03877393 | Medical University of Lublin | N/A |
| Completed | Nitrous Oxide for Major Depressive Disorder NCT03932825 | Lingjiang Li | Phase 2 |
| Completed | A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in NCT03854578 | Boehringer Ingelheim | Phase 1 |
| Completed | Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept NCT03715127 | University of Zurich | Phase 2 |
| Completed | Triple Chronotherapy in Adolescents NCT03679962 | Billings Clinic | N/A |
| Unknown | Vortioxetine for Treatment of Depressive Mood and Alcohol Use NCT04498897 | Hanyang University Seoul Hospital | Phase 2 |
| Completed | Coil Positioning in Navigated Transcranial Magnetic Stimulation Feasibility in Depression Patients Trial NCT03795051 | Magstim | N/A |
| Completed | Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms NCT03429075 | Imperial College London | Phase 2 |
| Completed | Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine NCT03367533 | Yale University | Phase 1 |
| Withdrawn | Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and NCT03758495 | VA Office of Research and Development | — |
| Terminated | Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD) NCT03675776 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Suspended | Ketamine Versus Electroconvulsive Therapy in Depression NCT03674671 | University of Ottawa | Phase 3 |
| Unknown | Ketamine for Treatment Resistant MDD NCT04021433 | Hadassah Medical Organization | N/A |
| Completed | Olfactory Training and Emotional State NCT03605524 | University Hospital, Tours | N/A |
| Terminated | Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) NCT03668600 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Terminated | Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD) NCT03614156 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Unknown | Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression NCT03944213 | University Hospital, Bonn | — |
| Completed | A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression NCT03559192 | Janssen Research & Development, LLC | Phase 2 |
| Terminated | Study of Rapastinel as Monotherapy in Patients With MDD NCT03560518 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Completed | Zelquistinel in the Treatment of Major Depressive Disorder NCT03586427 | Syndeio Biosciences, Inc | Phase 2 |
| Completed | Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA) NCT03548675 | Radboud University Medical Center | Phase 4 |
| Completed | Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 NCT03051256 | Relmada Therapeutics, Inc. | Phase 2 |
| Completed | Does Nurse Semi Structured Interview Added to a rTMS Improve Patients With Major Depressive Disorder? NCT03436823 | Rennes University Hospital | N/A |
| Completed | Sleep, Wake and Light Therapy for Depression NCT03405493 | King's College London | N/A |
| Completed | A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depre NCT03374475 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Attention Bias Modification Treatment for Young Adults With Major Depressive Disorder NCT03971903 | Hunan Normal University | N/A |
| Terminated | A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder NCT03352453 | Naurex, Inc, an affiliate of Allergan plc | Phase 2 |
| Completed | A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release a NCT03321526 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder NCT03288714 | Wave Neuroscience | N/A |
| Completed | Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan NCT03207503 | Duke University | — |
| Completed | Stepped Care AiTBS 2 Depression Study (Ghent) NCT03288675 | University Hospital, Ghent | N/A |
| Completed | Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensi NCT03185819 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Molecular Imaging of Brain Inflammation in Depressive Disorders NCT02983318 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult NCT03227224 | Janssen Research & Development, LLC | Phase 2 |
| Terminated | Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients NCT02737540 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Exploring Effects of Electroconvulsive Therapy on the Human Brain in Depression - The Danish ECT/MRI Study NCT03040388 | University of Copenhagen | — |
| Terminated | Feasibility of a Technology-Based Treatment Support System NCT03121937 | Northwestern University | N/A |
| Completed | 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehen NCT03097133 | Janssen Research & Development, LLC | Phase 3 |
| Completed | 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehen NCT03039192 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects NCT03155503 | Suven Life Sciences Limited | Phase 1 |
| Completed | Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide NCT03016572 | The Cleveland Clinic | N/A |
| Completed | Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to NCT03108625 | H. Lundbeck A/S | Phase 3 |
| Completed | Stepped Care for Depression in Heart Failure NCT02997865 | Washington University School of Medicine | N/A |
| Unknown | Probing Prefrontal Cortex Hemodynamic Alterations for Major Depression Disorder NCT03595020 | Xijing Hospital | — |
| Completed | Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder NCT03002077 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Terminated | NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits NCT02994433 | Washington University School of Medicine | Phase 1 |
| Completed | Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depress NCT03027362 | Yale University | N/A |
| Completed | Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies NCT03283670 | Washington University School of Medicine | Phase 2 |
| Completed | A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Dis NCT02951988 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Completed | Gaze Contingent Feedback in Major Depressive Disorder (MDD) NCT02945735 | Tel Aviv University | N/A |
| Completed | A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03) NCT02943577 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Completed | Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy? NCT02938559 | University of California, Berkeley | N/A |
| Completed | A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) NCT02943564 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Completed | Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Te NCT03014544 | Janssen Research & Development, LLC | — |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Maj NCT02902601 | Janssen Research & Development, LLC | Phase 1 |
| Completed | A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) NCT02932943 | Naurex, Inc, an affiliate of Allergan plc | Phase 3 |
| Completed | A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated Risks NCT03001440 | GlaxoSmithKline | — |
| Completed | A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road NCT02919579 | Janssen Research & Development, LLC | Phase 1 |
| Completed | The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar NCT03287037 | Tri-Service General Hospital | N/A |
| Completed | Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day NCT02919501 | H. Lundbeck A/S | Phase 2 |
| Terminated | Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants Wit NCT02871297 | H. Lundbeck A/S | Phase 3 |
| Completed | Stimulation of Parieto-hippocampal Connectivity in Patients With Major Depressive Disorder NCT04081519 | University Hospital, Bonn | N/A |
| Completed | Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness NCT02845440 | Massachusetts General Hospital | N/A |
| Completed | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tabl NCT02698553 | GlaxoSmithKline | Phase 1 |
| Completed | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years W NCT02709655 | H. Lundbeck A/S | Phase 3 |
| Completed | Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive Disorder NCT04013464 | Peking University Sixth Hospital | N/A |
| Completed | Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON Project NCT02664467 | Ospedale Regionale di Lugano | N/A |
| Completed | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With NCT02709746 | H. Lundbeck A/S | Phase 3 |
| Completed | Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients. NCT02741622 | St. Olavs Hospital | N/A |
| Completed | NMDA Modulation in Major Depressive Disorder in Late- Life NCT03414931 | Chang Gung Memorial Hospital | Phase 2 |
| Completed | Depression and Immune Function in Multiple Sclerosis (MS) NCT02740296 | Charite University, Berlin, Germany | — |
| Suspended | Predictors of Treatment Response in Late-onset Major Depressive Disorder NCT02546024 | King's College London | — |
| Completed | Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) NCT02452892 | Tal Medical, Inc. | N/A |
| Completed | Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD NCT03721588 | Bozyaka Training and Research Hospital | — |
| Completed | An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder NCT02473289 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disord NCT02466477 | Assurex Health Inc. | Phase 4 |
| Completed | Peripheral Immunomarker Validation in Treatment-resistant Depression NCT02752178 | University of Cambridge | — |
| Completed | NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial NCT02667041 | University of Ottawa | N/A |
| Completed | Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study NCT02739932 | University of Calgary | — |
| Unknown | The Effect of Traumatic Childbirth on the Incidence of PTSD and Other Major Postpartum Psychopathology NCT02370576 | Rambam Health Care Campus | — |
| Completed | E-Compared-CH: Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss Trial NCT02410616 | University of Bern | N/A |
| Completed | A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise NCT02407704 | Kirk Erickson, PhD | Phase 4 |
| Completed | Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, an NCT02191397 | GlaxoSmithKline | Phase 3 |
| Completed | Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder NCT02659085 | Pouya Movahed Rad | Phase 2 / Phase 3 |
| Completed | Combining Data Sources to Identify Effect Moderation for Personalized Mental Health NCT05267873 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD) NCT02489305 | Janssen Research & Development, LLC | — |
| Completed | A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major NCT02288325 | Forest Laboratories | Phase 4 |
| Completed | Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging NCT03899168 | Leibniz-Institut für Wissensmedien | N/A |
| Completed | Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression NCT04469322 | San Diego Veterans Healthcare System | N/A |
| Unknown | Ketamine Infusions for Major Depression Disorder NCT02219867 | Sheba Medical Center | N/A |
| Completed | Dialogue to Empower Traditional and Faith Healers to Deliver mhGAP-IG Adapted Psychosocial Interventions in Ke NCT03165513 | Africa Institute of Mental and Brain Health (AFRIMEB) | N/A |
| Completed | Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Pat NCT02529462 | AB Biotics, SA | Phase 3 |
| Completed | Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatmen NCT02196506 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females NCT02116361 | Allergan | Phase 2 |
| Completed | A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Ma NCT01870843 | Xian-Janssen Pharmaceutical Ltd. | Phase 4 |
| Completed | A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressiv NCT02067299 | Janssen Research & Development, LLC | Phase 1 |
| Completed | A Randomized Controlled Trial of PCIT-ED for Preschool Depression NCT02076425 | Washington University School of Medicine | N/A |
| Completed | The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of NCT04272476 | Chengdu University of Traditional Chinese Medicine | Phase 2 |
| Completed | PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011 NCT02039960 | GlaxoSmithKline | — |
| Unknown | Objective Diagnostic Markers and Personalized Intervention in MDD Patients NCT02023567 | Peking University | N/A |
| Completed | A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS) NCT01909232 | Cervel Neurotech, Inc. | N/A |
| Completed | A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive NCT01727726 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | Mommy-Baby Treatment for Perinatal Depression NCT01744041 | Washington University School of Medicine | N/A |
| Completed | Cortical Excitability and Inhibition in MDD NCT01718730 | Mayo Clinic | — |
| Completed | Whole Body Hyperthermia and Major Depression (MDD) NCT01625546 | University of Arizona | N/A |
| Completed | Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder NCT01564862 | Takeda | Phase 2 |
| Withdrawn | Brain Imaging, Genetics and Treatment for Major Depression NCT01568684 | National Institute of Mental Health (NIMH) | Phase 1 |
| Completed | Characterization of the Prosocial and Prosexual Effects of GHB NCT02342366 | University of Zurich | N/A |
| Completed | Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the NCT01360866 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Effect of Clarithromycin on LY2216684 NCT01460407 | Eli Lilly and Company | Phase 1 |
| Completed | A Study to Evaluate the Effect of Genotype on LY2216684 NCT01460381 | Eli Lilly and Company | Phase 1 |
| Completed | Buprenorphine for Treatment Resistant Depression NCT01407575 | University of Pittsburgh | Phase 3 |
| Completed | Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial NCT01583400 | Dartmouth-Hitchcock Medical Center | N/A |
| Completed | A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects NCT01389752 | Eli Lilly and Company | Phase 1 |
| Completed | Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With NCT01360645 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Effect of Food on LY2216684 NCT01389765 | Eli Lilly and Company | Phase 1 |
| Completed | Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adu NCT01360632 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Completed | A Study of LY2216684 in Healthy Females NCT01373931 | Eli Lilly and Company | Phase 1 |
| Completed | European Deep Brain Stimulation (DBS) Depression Study NCT01331330 | Abbott Medical Devices | N/A |
| Completed | Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD) NCT01284218 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — |
| Completed | Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder NCT01255787 | Takeda | Phase 2 / Phase 3 |
| Completed | Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features NCT01477931 | Chi-Un Pae | Phase 4 |
| Completed | A Study of LY2216684 in Participants With Impaired Hepatic Function NCT01241435 | Eli Lilly and Company | Phase 1 |
| Completed | A Safety Study in Participants With Major Depressive Disorder NCT01155661 | Eli Lilly and Company | Phase 3 |
| Completed | Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study NCT01152996 | Takeda | Phase 3 |
| Completed | Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder NCT01179516 | Takeda | Phase 3 |
| Completed | Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder NCT01163266 | Takeda | Phase 3 |
| Completed | A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD) NCT01138007 | GlaxoSmithKline | Phase 3 |
| Completed | Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder NCT01153009 | Takeda | Phase 3 |
| Completed | Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder NCT01033084 | University of Sao Paulo | Phase 2 / Phase 3 |
| Completed | Clinical Study to Test a New Drug to Treat Major Depression NCT00976560 | GlaxoSmithKline | Phase 2 |
| Completed | An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated NCT01814098 | Xian-Janssen Pharmaceutical Ltd. | Phase 4 |
| Completed | Insulin Resistance in Patients With Major Depression NCT01106313 | Stanford University | — |
| Completed | GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression NCT00931619 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use NCT01141400 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — |
| Completed | Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder NCT00892463 | Sunnybrook Health Sciences Centre | Phase 4 |
| Completed | Outcomes in MEasurement-Based Treatment NCT01141387 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — |
| Completed | Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression NCT00928980 | Radboud University Medical Center | N/A |
| Terminated | A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and S NCT00880399 | GlaxoSmithKline | Phase 2 |
| Completed | A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder NCT00840034 | Eli Lilly and Company | Phase 2 |
| Completed | Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder NCT00824291 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive NCT00844194 | Boehringer Ingelheim | Phase 4 |
| Completed | A Study in Adult Patients With Major Depressive Disorder NCT00795821 | Eli Lilly and Company | Phase 2 / Phase 3 |
| Completed | A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder NCT00733980 | GlaxoSmithKline | Phase 2 |
| Enrolling By Invitation | Psychiatric Genotype/Phenotype Project Repository NCT00762866 | Vanderbilt University | — |
| Completed | Switching to Duloxetine in Patients With Depression NCT00696774 | Eli Lilly and Company | Phase 4 |
| Completed | Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome NCT00671515 | Joseph Calabrese, MD | Phase 2 |
| Completed | A Study of Transcranial Direct Current Stimulation (tDCS) to Treat Depression NCT00763230 | The University of New South Wales | Phase 2 / Phase 3 |
| Completed | Advanced MRI in Major Depression NCT00613912 | University of Aarhus | — |
| Terminated | Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients NCT00655226 | Icahn School of Medicine at Mount Sinai | N/A |
| Terminated | Deep Brain Stimulation for Major Depressive Disorder NCT00617162 | Abbott Medical Devices | N/A |
| Completed | Decentering and Relapse/Recurrence in MBCT for Depression in Adults NCT05111665 | University of British Columbia | N/A |
| Completed | An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder NCT00629551 | Sanofi | Phase 3 |
| Completed | Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression NCT00627887 | Örebro County Council | Phase 4 |
| Completed | A Safety, Efficacy and Tolerability Study of SEP-225289 NCT00584974 | Sumitomo Pharma America, Inc. | Phase 2 |
| Completed | SA4503 8-Week Study in Major Depressive Disorder (MDD) NCT00551109 | M's Science Corporation | Phase 2 |
| Completed | Patient Tolerability Study of GSK163090 NCT00559299 | GlaxoSmithKline | Phase 1 |
| Completed | Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Dis NCT01145313 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — |
| Terminated | A Study of GW856553X For the Treatment of Depression NCT00569062 | GlaxoSmithKline | Phase 2 |
| Completed | Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD NCT00445679 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Auricular Acupuncture vs. Progressive Muscle Relaxation in Patients With Anxiety Disorders or Major Depressive NCT02340351 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Completed | St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety NCT00451516 | The University of Queensland | Phase 2 |
| Completed | Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression NCT02229825 | Boehringer Ingelheim | Phase 4 |
| Completed | Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (D NCT00440427 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway NCT00456898 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women NCT00406640 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | A Local Register Study For Major Depression Of Paroxetine Controlled Release NCT00368303 | GlaxoSmithKline | Phase 3 |
| Completed | Study for Evaluating Different Methods of Measuring Depression Treatment Response NCT00406952 | Pfizer | N/A |
| Withdrawn | The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder NCT00451490 | National Taiwan University Hospital | N/A |
| Completed | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausa NCT00369343 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Diso NCT00384033 | Pfizer | Phase 3 |
| Completed | Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjec NCT00366652 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels NCT00370058 | University of Erlangen-Nürnberg Medical School | Phase 4 |
| Completed | Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Tal NCT00401726 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Open-label Ziprasidone Study for Psychosis Treatment in Adolescents NCT00421954 | New York State Psychiatric Institute | Phase 3 |
| Completed | AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment NCT00304746 | Mclean Hospital | Phase 4 |